Terms: = Skin cancer AND GATA3, HDR, 2625, ENSG00000107485, MGC5445, MGC5199, MGC2346 AND Treatment
150 results:
1. Salvage re-irradiation in non-melanoma skin cancers: A multicenter analysis.
Miszczyk M; Suleja A; Sobel S; Stec M; Chyrek AJ; Kolbusz M; Spałek M; Nasiek A; Stankiewicz M; Lelek P; Moll M; Kluska A; Kazalski D; Saniewski P; Kaminiów K; Burchardt WM; Wojcieszek P; Chicheł A; Cichoń P; Krzysztofiak T
Radiother Oncol; 2023 Dec; 189():109945. PubMed ID: 37806558
[TBL] [Abstract] [Full Text] [Related]
2. Organ sparing treatment for penile cancer using a 3D-printed high-dose-rate brachytherapy applicator.
Lee HHC; Chiu TD; Hrycushko B; Xiong Z; Hudak S; Woldu S; Mauck R; Corwin T; Meng X; Margulis V; Desai N; Folkert MR; Garant A
Brachytherapy; 2023; 22(5):580-585. PubMed ID: 37474438
[TBL] [Abstract] [Full Text] [Related]
3.
Hadadi A; Ghanavati S
Appl Radiat Isot; 2023 Jul; 197():110786. PubMed ID: 37023694
[TBL] [Abstract] [Full Text] [Related]
4. First clinical implementation of Yttrium-90 Disc Brachytherapy after FDA clearance.
Finger PT; Stewart R; Rivard MJ; Beers RJ; Kamen J; Lama S; Chin KJ; Mohney K; Welles TS; Sauerwein WAG; Rosenzweig K
Brachytherapy; 2023; 22(3):416-427. PubMed ID: 36948988
[TBL] [Abstract] [Full Text] [Related]
5. The Value of Immunohistochemical Expression of TOX, ICOS, and GATA-3 in the Diagnosis of Mycosis Fungoides.
Atwa HA; Abdelrahman DI
Appl Immunohistochem Mol Morphol; 2023 Mar; 31(3):163-171. PubMed ID: 36805367
[TBL] [Abstract] [Full Text] [Related]
6. Customized 3D-printed molds for high dose-rate brachytherapy in facial skin cancer: First clinical experience.
Chatzikonstantinou G; Diefenhardt M; Fleischmann M; Meissner M; Scherf C; Trommel M; Ramm U; Rödel C; Tselis N; Licher J
J Dtsch Dermatol Ges; 2023 Jan; 21(1):35-41. PubMed ID: 36657038
[TBL] [Abstract] [Full Text] [Related]
7. Top cited publications for treatment of keloid with radiotherapy: A Bibliometric analysis.
Siavashpour Z; Houshyari M; Dadkhahfar S; Jafari A
J Cancer Res Ther; 2023 Jan; 19(Suppl 2):S472-S476. PubMed ID: 38384007
[TBL] [Abstract] [Full Text] [Related]
8. High-dose-rate brachytherapy in scrotal extramammary Paget's disease: A case report.
Risso S; Amendola BE; Perez NC; Amendola M
Brachytherapy; 2023; 22(2):210-213. PubMed ID: 36509648
[TBL] [Abstract] [Full Text] [Related]
9. Single-cell analyses reveal novel molecular signatures and pathogenesis in cutaneous T cell lymphoma.
Xue X; Wang Z; Mi Z; Liu T; Wang C; Shi P; Sun L; Yang Y; Li W; Wang Z; Liu H; Zhang F
Cell Death Dis; 2022 Nov; 13(11):970. PubMed ID: 36400759
[TBL] [Abstract] [Full Text] [Related]
10. hdr brachytherapy in keratinocyte skin carcinomas - Single center experience with analysis of clinical, dosimetric, and radiobiological factors in acute skin toxicity.
Rodríguez Villalba S; Guirado LLorente D; Sanz Cazorla A; Perez-Calatayud J; Rembielak A
Brachytherapy; 2023; 22(1):108-119. PubMed ID: 36376228
[TBL] [Abstract] [Full Text] [Related]
11. Novel portable apparatus for outpatient high-dose-rate (hdr) brachytherapy in penile cancer.
Rishi A; Saini AS; Spiess PE; Yu A; Fernandez DC; Johnstone PAS; Naghavi AO
Brachytherapy; 2022; 21(6):839-847. PubMed ID: 35915039
[TBL] [Abstract] [Full Text] [Related]
12. High dose rate brachytherapy in nonmelanoma skin cancer-Systematic review.
Krzysztofiak T; Kamińska-Winciorek G; Pilśniak A; Wojcieszek P
Dermatol Ther; 2022 Sep; 35(9):e15675. PubMed ID: 35770511
[TBL] [Abstract] [Full Text] [Related]
13. Electronic brachytherapy for non-melanoma skin cancer in Asians: Experience from a Taiwan medical center.
Tang TY; Tang JY; Chu-Sung Hu S; Chiao-Li Ke K; Cheng ST
J Formos Med Assoc; 2022 Nov; 121(11):2317-2323. PubMed ID: 35570050
[TBL] [Abstract] [Full Text] [Related]
14. Four-fraction ultra-accelerated minimal breast irradiation in early breast cancer: The initial feasibility results of an institutional experience.
Morales MG; Martínez-Monge R; Martínez-Regueira F; Rodriguez-Spiteri N; Olartecoechea B; Ramos L; Ayestarán A; Insausti LP; Elizalde A; Abengozar M; Rubio I; Esgueva A; Sobrido C; Cambeiro M
Brachytherapy; 2022; 21(4):475-486. PubMed ID: 35396137
[TBL] [Abstract] [Full Text] [Related]
15. Dose volume histogram constraints in patients with soft tissue sarcomas of the extremities and the superficial trunk treated with surgery and perioperative hdr brachytherapy.
Gómez-Álvarez J; Martín Pastor S; Gimeno M; Lamo-Espinosa J; Ramos LI; Cambeiro M; Tagliaferri L; Kovacs G; Strnad V; San-Julián M; Martinez-Monge R
Radiother Oncol; 2022 May; 170():159-164. PubMed ID: 35227732
[TBL] [Abstract] [Full Text] [Related]
16. Poorly Differentiated Scrotal Carcinoma With Apocrine Immunophenotype.
Kamanda S; Epstein JI; Osunkoya AO; Cimino-Mathews A; Argani P; Sangüeza M; Plaza JA; Matoso A
Am J Dermatopathol; 2022 Apr; 44(4):260-266. PubMed ID: 34726185
[TBL] [Abstract] [Full Text] [Related]
17. Seven key hub genes identified by gene co-expression network in cutaneous squamous cell carcinoma.
Chen H; Yang J; Wu W
BMC Cancer; 2021 Jul; 21(1):852. PubMed ID: 34301206
[TBL] [Abstract] [Full Text] [Related]
18. A review of dosimetric impact of implementation of model-based dose calculation algorithms (MBDCAs) for hdr brachytherapy.
Yousif YAM; Osman AFI; Halato MA
Phys Eng Sci Med; 2021 Sep; 44(3):871-886. PubMed ID: 34142317
[TBL] [Abstract] [Full Text] [Related]
19. Multidisciplinary approach to nose vestibule malignancies: setting new standards.
Bussu F; Tagliaferri L; Piras A; Rizzo D; Tsatsaris N; De Corso E; Parrilla C; Paludetti G
Acta Otorhinolaryngol Ital; 2021 Apr; 41(Suppl. 1):S158-S165. PubMed ID: 34060531
[TBL] [Abstract] [Full Text] [Related]
20. Tumor control and cosmetic outcome of weekly iridium-192 high-dose-rate brachytherapy for nonmelanoma skin cancers in the elderly.
Roberson J; Patel R; Slutsky JB; Ryu S; Xu Z; Valentine E
Brachytherapy; 2021; 20(4):818-827. PubMed ID: 33789824
[TBL] [Abstract] [Full Text] [Related]
[Next]
